Volume | 380,402 |
|
|||||
News | - | ||||||
Day High | 22.52 | Low High |
|||||
Day Low | 21.33 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Castle Biosciences Inc | CSTL | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
21.37 | 21.33 | 22.52 | 22.15 | 21.28 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
4,433 | 380,402 | $ 22.27 | $ 8,470,403 | - | 9.2601 - 26.70 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:38:06 | 20 | $ 22.15 | USD |
Castle Biosciences Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
608.02M | 27.45M | - | 219.79M | -57.47M | -2.09 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Castle Biosciences News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CSTL Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 20.52 | 22.52 | 20.12 | 21.02 | 206,371 | 1.63 | 7.94% |
1 Month | 24.85 | 24.8739 | 17.42 | 20.16 | 314,149 | -2.70 | -10.87% |
3 Months | 20.83 | 25.60 | 17.42 | 21.57 | 257,948 | 1.32 | 6.34% |
6 Months | 16.41 | 25.60 | 12.07 | 19.27 | 263,517 | 5.74 | 34.98% |
1 Year | 22.42 | 26.70 | 9.2601 | 17.87 | 384,918 | -0.27 | -1.20% |
3 Years | 59.19 | 78.92 | 9.2601 | 29.77 | 283,563 | -37.04 | -62.58% |
5 Years | 20.00 | 107.69 | 9.2601 | 34.68 | 254,647 | 2.15 | 10.75% |
Castle Biosciences Description
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. |